Metsera is riding the wave of continued enthusiasm for GLP-1 drugs and its own early-stage data to bring in a hefty $215 million series B fundraise. The biotech said it would use the cash to “further ...
CHICAGO--(BUSINESS WIRE)--Ocient, the leading data analytics software solutions company, today announced its advancement into growth stage following the successful close of its $132M Series B funding, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback